Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00590135 · ClinicalTrials.gov registry record · Phase 4
The Effect of Lipitor on Aortic Stenosis
A Phase 4 study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- Phase 4
- Development phase
- 59
- Enrollment target
NCT00590135 is a Phase 4 study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 59 participants.
The verdict
NCT00590135, a Phase 4 study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 59 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if an approved medicine that is used to lower cholesterol called Lipitor can slow or stop progressive narrowing of the aortic heart valve in patients with a condition called aortic stenosis. Patients who have aortic stenosis who volunteer for this study will take Lipitor for 2 years and will undergo a brief exam by a physician, labwork to measure cholesterol, and a routine heart ultrasound (sound picture of the heart) at the start of the study and every 6 months, stopping at 2 years.
Interventions
- DRUG atorvastatin (Lipitor)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2000-08 |
| Est. Completion | 2010-04-26 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00590135
The ClinicalTrials.gov registry entry for NCT00590135 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which atorvastatin (Lipitor) is the first listed.
NCT00590135 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00590135 about?
NCT00590135 is a clinical study titled "The Effect of Lipitor on Aortic Stenosis". The purpose of this study is to find out if an approved medicine that is used to lower cholesterol called Lipitor can slow or stop progressive narrowing of the aortic heart valve in patients with a condition called aortic stenosis. Patients who have aortic stenosis who volunteer for this study will ...
What is the current status of trial NCT00590135?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 59 participants. The study started on 2000-08. Estimated completion is 2010-04-26.
What interventions are being tested in trial NCT00590135?
The interventions under investigation include: atorvastatin (Lipitor) (DRUG).
Who is sponsoring clinical trial NCT00590135?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.